Cargando…
Characterization of Thyroid Disease Prevalence Among Transgender and Gender-Diverse Patients
Objective: Transgender and gender-diverse individuals are at risk of insufficient treatment of endocrine diseases due to a number of barriers to care. There are currently no data evaluating the prevalence of thyroid disease in this population, and it is unknown if gender-affirming hormone therapy af...
Autores principales: | Christensen, John David, Davidge-Pitts, Caroline, Castro, M Regina, Caraballo, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090061/ http://dx.doi.org/10.1210/jendso/bvab048.1709 |
Ejemplares similares
-
An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021) -
Breast Cancer Screening Recommendations for Transgender and Gender Diverse Patients: A Knowledge and Familiarity Assessment of Primary Care Practitioners
por: Carroll, Evelyn F., et al.
Publicado: (2023) -
133 Investigating the Utilization Rate of Fertility Preservation Services Amongst Transgender and Gender Diverse Patients
por: DSouza, Karen, et al.
Publicado: (2022) -
Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021) -
FRI525 Gender Differences In Fears Related To Low Risk Papillary Thyroid Cancer And Its Treatment
por: Sawka, Anna M, et al.
Publicado: (2023)